IFG
CRBP icon

Investors Financial Group’s Corbus Pharmaceuticals CRBP Stock Holding History

Investors Financial Group’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-333
Closed -$10K – 213
2021
Q3 		$10K Hold
333
– – 0.01% 198
2021
Q2 		$18K Hold
333
– – 0.01% 203
2021
Q1 		$20K Hold
333
– – 0.01% 192
2020
Q4 		$13K Buy
+333
New +$12.4K 0.01% 164

Other funds holding CRBP

EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Investors Financial Group's CRBP Position: Q4 2021 in Review

Investors Financial Group sold out of Corbus Pharmaceuticals (CRBP) in Q4 2021, closing a stake of 333 shares — an estimated $10K sold.

Investors Financial Group first reported a position in CRBP in Q4 2020 and held it in 4 quarters. The position peaked at $20K in Q1 2021. 82 funds tracked by Wall St. Rank hold CRBP as of Q4 2021.

  • Investors Financial Group reported no remaining Corbus Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Investors Financial Group sold 333 Corbus Pharmaceuticals shares in Q4 2021, an estimated $10K.
  • Investors Financial Group first reported a position in Corbus Pharmaceuticals in Q4 2020 and held it in 4 quarters.
  • Investors Financial Group's Corbus Pharmaceuticals position peaked at $20K in Q1 2021.
  • 82 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q4 2021.

Based on Investors Financial Group's 13F filing for Q4 2021, filed 14 Jan 2022.